Products in Development
Bioniche has developed a technology for the treatment of human cancers. The first product developed from this technology is Urocidin™, a formulation of Mycobacterial Cell Wall-DNA Complex (MCC) for the treatment of bladder cancer. A Phase III clinical program is underway, with one Phase III clinical trial completed.
For more information about the Company’s clinical programs, please contact Bioniche Therapeutics at email@example.com
Animal Health Products
Information about Bioniche Animal Health products can be found at www.bionicheanimalhealth.com
One Health Products
Econiche™ is the first marketed product of the Bioniche One Health division.
Contact Bioniche One Health